Articles related to INTRAOCULAR LENS (IOL)

Alcon’s Clareon TruPlus adds an enhanced monofocal option aimed at improving intermediate vision while preserving distance quality, with real‑world outcomes yet to be defined.

TECNIS PureSee IOL is the first and only US FDA‑approved extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity

Blake Williamson, MD, MPH, MS, demonstrates femtosecond laser assisted cataract surgery (FLACS) with a toric lens and iStent inject.

For a comprehensive approach to refractive IOL surgery, understanding the nuances of preoperative assessment and ocular surface optimization is essential. Dive deeper into effective protocols to ensure optimal patient outcomes.

After cataract surgery, a fragment of the lens is thought to stay in the eye in 0.3% to 1.1% of cases. Following cataract surgery, the retained cortex and nucleus respond differently: While the nucleus triggers a potent, destructive inflammatory response, the cortex only induces low-grade inflammation. Increased postoperative drops are administered more frequently, and if necessary, IOP-lowering medications are added.

The most difficult aspect of epiretinal membrane (ERM) peeling may be the timing — early removal allows the membrane to reappear, whereas later surgery may impair restored visual acuity. An analysis published in BMC Ophthalmology evaluates clinical outcomes for patients with diffractive multifocal intraocular lenses (MIOLs) and compares how changing levels of ERM affect recovery.